Associations between baseline and 1-year time-integrated measures of inflammation and 3-year change in radiographic damage (univariate linear regression analyses)
Independent variables: baseline measures | Independent variables: 12 months AUC of inflammatory markers | |||||
---|---|---|---|---|---|---|
β (95% CI) | R2 | p Value | β (95% CI) | R2 | p Value | |
Baseline characteristics | ||||||
Female | −0.36 (−0.96 to 0.25) | 0.02 | 0.24 | |||
Age | −0.002 (−0.02 to 0.02) | 0.001 | 0.82 | |||
Anti-CCP positivity | 0.50 (−0.16 to 1.15) | 0.04 | 0.13 | |||
Clinical measures of disease activity | ||||||
28-SJC | 0.03 (−0.03 to 0.08) | 0.01 | 0.31 | 0.01 (−0.001 to 0.02) | 0.06 | 0.07 |
28-TJC | −0.01 (−0.05 to 0.03) | 0.004 | 0.57 | −0.002 (−0.01 to 0.005) | 0.01 | 0.56 |
DAS28 | 0.14 (−0.05 to 0.32) | 0.03 | 0.15 | 0.02 (−0.01 to 0.05) | 0.03 | 0.19 |
Serological markers of inflammation | ||||||
ESR | 0.02 (0.01 to 0.04) | 0.09 | 0.01† | 0.004 (0.001 to 0.01) | 0.11 | 0.02† |
CRP | 0.01 (−0.001 to 0.03) | 0.05 | 0.06 | 0.01 (0.001 to 0.01) | 0.09 | 0.03† |
MRI measures of inflammation | ||||||
MRI synovitis | 0.14 (0.01 to 0.26) | 0.06 | 0.03† | 0.03 (0.01 to 0.05) | 0.13 | 0.01† |
MRI bone marrow oedema | 0.06 (0.02 to 0.10) | 0.08 | 0.01† | 0.01 (0.004 to 0.02) | 0.15 | 0.004† |
MRI tenosynovitis | −0.02 (−0.09 to 0.05) | 0.01 | 0.54 | 0.005 (−0.01 to 0.02) | 0.01 | 0.43 |
↵† p≤0.05.
28-SJC, 28-swollen joint count; 28-TJC, 28-tender joint count; anti-CCP, anti-citrullinated protein antibodies; AUC, area under the curve; CRP, C reactive protein; DAS28, disease activity score based on 28 joint counts; ESR, erythrocyte sedimentation rate; R2, fraction of explained variance; vdHSS, van der Heijde Sharp score.